Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

ARS Pharmaceuticals

Tracked across 2 events · 180 articles · First seen Jun 26, 2026 · Last active Sep 22, 2026

Sentiment
-62
Attention
4
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -70
Regulatory
Impact: ARS Pharmaceuticals is under investigation for potential violations of federal securities laws due to allegedly misleading statements regarding Neffy's commercial coverage, which led to a significant stock price drop.
Jun 26, 2026 · 6 articles
2 -55
Regulatory
Multiple investor-rights law firms have filed securities class action lawsuits against ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) and certain of its officers, alleging violations of federal securities laws during the class period of March 9, 2026…
Impact: ARS Pharmaceuticals is the defendant in the securities class actions and the central subject of the event. The litigation and the underlying neffy coverage setback weigh on its stock, financing options, and reputation.
Aug 06, 2026 · 174 articles
45 ARS Pharmaceuticals guided on coverage expansionARS Pharmaceuticals neffy...
CVS Health ↔ ARS Pharmaceuticals
CVS Health ↔ ARS Pharmaceuticals
ERGEN INTELLIGENCE
Track ARS Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.